IS8366A - Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðuhjúpaða með sýrufjölliðu - Google Patents

Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðuhjúpaða með sýrufjölliðu

Info

Publication number
IS8366A
IS8366A IS8366A IS8366A IS8366A IS 8366 A IS8366 A IS 8366A IS 8366 A IS8366 A IS 8366A IS 8366 A IS8366 A IS 8366A IS 8366 A IS8366 A IS 8366A
Authority
IS
Iceland
Prior art keywords
pyrimidine
derivative
coated
pharmaceutical preparation
acid polymer
Prior art date
Application number
IS8366A
Other languages
English (en)
Other versions
IS2677B (is
Inventor
Marinus Johannes Van Schie Dirk
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS8366A publication Critical patent/IS8366A/is
Publication of IS2677B publication Critical patent/IS2677B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8366A 2003-09-02 2006-03-20 Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðu hjúpaða með sýrufjölliðu IS2677B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320522.6A GB0320522D0 (en) 2003-09-02 2003-09-02 Formulation
PCT/EP2004/009726 WO2005021002A1 (en) 2003-09-02 2004-08-31 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Publications (2)

Publication Number Publication Date
IS8366A true IS8366A (is) 2006-03-20
IS2677B IS2677B (is) 2010-09-15

Family

ID=28686767

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8366A IS2677B (is) 2003-09-02 2006-03-20 Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðu hjúpaða með sýrufjölliðu

Country Status (30)

Country Link
US (2) US20060287346A1 (is)
EP (1) EP1663243B1 (is)
JP (1) JP4892346B2 (is)
KR (1) KR101115984B1 (is)
CN (2) CN1874778B (is)
AR (1) AR045547A1 (is)
AT (1) ATE422889T1 (is)
AU (1) AU2004268376B2 (is)
BR (1) BRPI0414038A (is)
CA (1) CA2537178C (is)
CY (1) CY1108953T1 (is)
DE (1) DE602004019547D1 (is)
DK (1) DK1663243T3 (is)
ES (1) ES2319124T3 (is)
GB (1) GB0320522D0 (is)
HR (1) HRP20090147T3 (is)
IL (1) IL173910A (is)
IS (1) IS2677B (is)
MA (1) MA28033A1 (is)
MX (1) MXPA06002436A (is)
MY (1) MY139165A (is)
NO (1) NO333744B1 (is)
NZ (1) NZ545453A (is)
PL (1) PL1663243T3 (is)
PT (1) PT1663243E (is)
RU (1) RU2359660C2 (is)
SI (1) SI1663243T1 (is)
TW (1) TWI343257B (is)
WO (1) WO2005021002A1 (is)
ZA (1) ZA200601599B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
EP2977452A3 (en) 2007-05-11 2016-05-25 Thomas Jefferson University Methods of treatment and prevention of neurodegenerative diseases and disorders
CN101687009A (zh) 2007-05-11 2010-03-31 宾夕法尼亚大学理事会 治疗皮肤溃疡的方法
KR101580656B1 (ko) 2009-04-24 2015-12-30 아이슈티카 피티와이 리미티드 디클로페낙의 신규 제형
ES2847883T3 (es) 2010-12-17 2021-08-04 Glaxo Group Ltd Uso de inhibidores de LP-PLA2 en el tratamiento y prevención de enfermedades oculares
WO2013082275A1 (en) 2011-11-30 2013-06-06 Trustees Of Boston College Inhibitors of phosphodiesterases 11 (pde11) and methods of use to elevate cortisol production
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
CN106536525B (zh) 2014-07-22 2019-05-03 葛兰素史密斯克莱知识产权发展有限公司 化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619570C1 (en) 1986-06-11 1987-10-29 Kneipp Werke Kneipp Mittel Zen Coated garlic tablet
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
TW209174B (is) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
AU717817B2 (en) * 1996-06-06 2000-04-06 Bifodan A/S Enteric coating, comprising alginic acid, for an oral preparation
DE59702733D1 (de) * 1996-08-15 2001-01-11 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
DE69934505T2 (de) * 1998-05-18 2007-10-04 Takeda Pharmaceutical Co. Ltd. Im munde zerfallende tablette enthaltend ein benzimidazole
CZ20011629A3 (cs) 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
US6268385B1 (en) * 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
NZ520752A (en) * 2000-02-16 2004-03-26 Smithkline Beecham P Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
KR100786927B1 (ko) * 2000-06-28 2007-12-17 스미스클라인비이참피이엘시이 습식 분쇄방법
ES2366430T3 (es) 2001-06-20 2011-10-20 Takeda Pharmaceutical Company Limited Método para fabricar comprimidos.
JP5138856B2 (ja) * 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
RU2203671C1 (ru) * 2002-03-25 2003-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Противовирусный лекарственный препарат для перорального применения
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation

Also Published As

Publication number Publication date
NO333744B1 (no) 2013-09-09
CY1108953T1 (el) 2014-07-02
RU2006110546A (ru) 2006-08-10
BRPI0414038A (pt) 2006-10-24
DK1663243T3 (da) 2009-05-04
IL173910A0 (en) 2006-07-05
NZ545453A (en) 2009-12-24
TW200517113A (en) 2005-06-01
GB0320522D0 (en) 2003-10-01
TWI343257B (en) 2011-06-11
SI1663243T1 (sl) 2009-06-30
CN1874778A (zh) 2006-12-06
DE602004019547D1 (de) 2009-04-02
CN1874778B (zh) 2011-06-22
EP1663243A1 (en) 2006-06-07
PL1663243T3 (pl) 2009-07-31
MXPA06002436A (es) 2006-06-20
PT1663243E (pt) 2009-04-27
CN102204891B (zh) 2013-08-21
KR20060118422A (ko) 2006-11-23
US20090306113A1 (en) 2009-12-10
ES2319124T3 (es) 2009-05-04
EP1663243B1 (en) 2009-02-18
AU2004268376A1 (en) 2005-03-10
IS2677B (is) 2010-09-15
HRP20090147T3 (hr) 2009-04-30
ATE422889T1 (de) 2009-03-15
ZA200601599B (en) 2007-05-30
WO2005021002A1 (en) 2005-03-10
JP4892346B2 (ja) 2012-03-07
HK1091734A1 (en) 2007-01-26
KR101115984B1 (ko) 2012-03-13
MA28033A1 (fr) 2006-07-03
MY139165A (en) 2009-08-28
IL173910A (en) 2010-11-30
AR045547A1 (es) 2005-11-02
US8772303B2 (en) 2014-07-08
CA2537178C (en) 2013-03-19
JP2007504195A (ja) 2007-03-01
RU2359660C2 (ru) 2009-06-27
US20060287346A1 (en) 2006-12-21
CN102204891A (zh) 2011-10-05
AU2004268376B2 (en) 2010-04-22
NO20061514L (no) 2006-04-03
CA2537178A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
IS2946B (is) Lyfjablanda sem felur í sér andrógen
DE602004017700D1 (de) Transmukosen verabreichung
DE60320177D1 (de) Wässrige Zusammensetzung enthaltend Polymernanopartikel
IS8353A (is) Lyfjablanda sem felur í sér lantanefnasambönd
DK1660431T3 (da) Phenoxyeddikesyrederivater
ATE383329T1 (de) Biaryloxymethylarenecarbonsäure
FI7846U1 (fi) Farmaseuttinen valmiste, joka sisältää oksikodonia ja naloksonia
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
DK1692242T3 (da) Viskoelastisk syre
DE60209252D1 (de) Stabilisierte polymerzusammensetzung
DK1587478T3 (da) Farmaceutisk sammensætning
GB0320994D0 (en) Aqueous polymer compositions
IS8351A (is) Lyfjaafurðir sem fela í sér bisfosfónöt
NO20033042D0 (no) Cyklodekstrin-inneholdende farmasöytisk preparat
DE602004013003D1 (de) Halbleitendes Polymer
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
DE602004024220D1 (de) Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
ATE546141T1 (de) Pharmazeutisches injektionspräparat
IS8366A (is) Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðuhjúpaða með sýrufjölliðu
DK1474152T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende ivabradin
EP1673349A4 (en) Benzimidazole derivatives: Preparation and pharmaceutical applications
IS7488A (is) Dreyfasamsetning í föstu formi
PT1603550E (pt) Composição farmacêutica que compreende ácido 5-metil-2-2¿- (cloro-6¿-fluoroanilino)fenilacético
IS7290A (is) Lyfjasamsetningar sem innihalda risperidone
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin